A Study of CAR-T Cells Targeting GPRC5D in the Treatment of r/r Multiple Myeloma
Clinical trial NCT05016778 · UNKNOWN
Trial details
- NCT number
- NCT05016778
- Sponsor
- Zhejiang University
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-08
- Primary completion
- 2024-06-30
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.